Repurposed Therapeutics

Organisation

Trials

  • NCT05886660

    Phase 2, Status unknown, 30 people, 2 Jun 2023

  • NCT05852730

    Phase 2, Status unknown, 80 people, 10 May 2023

  • NCT05548270

    Phase 3, Completed, 503 people, 21 Sept 2022

  • NCT04947423

    Phase 3, Completed, 140 people, 1 Jul 2021

  • NCT04272255

    Phase 3, Status unknown, 300 people, 17 Feb 2020

  • NCT04219982

    Phase 2/3, Terminated, 23 people, 7 Jan 2020

  • NCT04184115

    Phase 3, Completed, 102 people, 3 Dec 2019

  • NCT03988530

    Phase 3, Completed, 98 people, 17 Jun 2019

  • NCT03986905

    Phase 3, Completed, 300 people, 14 Jun 2019

  • NCT03874130

    Phase 1, Status unknown, 130 people, 14 Mar 2019

  • NCT02155309

    Phase 2/3, Terminated, 63 people, 4 Jun 2014